Table 6 Serum urate in median and inter-quartile range (IQR) at baseline (BL) and after weight loss at 6 months (M6), 12 months (M12) and 24 months (M24) in women and men with psoriatic arthritis and obesity
| S-urate μmol/L | BL | M6 | M12 | M24 |
BL-M6 p-value |
BL-M12 p-value |
BL-M24 p-value |
|---|---|---|---|---|---|---|---|
| All patients |
330 (280–400) N = 39 |
301 (244–356) N = 39 |
306 (250–348) N = 39 |
324 (264–351) N = 35 | 0.001 | 0.001 | 0.005 |
| Women |
309 (269–361) N = 25 |
259 (232–350) N = 25 |
286 (242–348) N = 25 |
294 (234–338) N = 21 | 0.023 | 0.053 | 0.033 |
| Men |
394 (324–416) N = 14 |
324 (304–367) N = 14 |
319 (294–357) N = 14 |
334 (306–368) N = 14 | 0.017 | 0.003 | 0.064 |
| All controls |
350 (283–384) N = 39 |
280 (243–356) N = 39 |
306 (267–352) N = 39 | N.A. | < 0.001 | 0.001 | N.A. |
| Women |
309 (278–366) N = 29 |
266 (230–299) N = 29 |
283 (235–321) N = 29 | N.A. | 0.001 | 0.002 | N.A. |
| Men |
400 (355–461) N = 10 |
359 (332–436) N = 10 |
372 (339–445) N = 10 | N.A. | 0.214 | 0.139 | N.A. |